Кардиометаболические факторы риска развития тяжелого течения COVID-19
Атеросклероз, 2022 Е. Стрюкова +4 more
doaj +1 more source
[Testosterone and Alzheimer's disease]. [PDF]
Probl Endokrinol (Mosk), 2022 Kuznetsov KO +10 more
europepmc +1 more source
[Type 2 amiodarone-induced thyrotoxicosis: prevalence, time and predictors of development]. [PDF]
Probl Endokrinol (Mosk), 2023 Ermolaeva AS, Fadeev VV.
europepmc +1 more source
[Clinical guidelines «Polycystic Ovary Syndrome»]. [PDF]
Probl Endokrinol (Mosk), 2022 Adamyan LV +10 more
europepmc +1 more source
[Surgical treatment of pheochromocytoma]. [PDF]
Probl Endokrinol (Mosk), 2023 Shikhmagomedov SS +8 more
europepmc +1 more source
The Rising Cases of Suicide among Nigerians: What Are the Risk Factors, Prevention, and Remedies? [PDF]
Consort PsychiatrAbamara NC, Ozongwu OE.
europepmc +1 more source
[Effect of components of the renin-angiotensin system, rs2106809 polymorphism of the ACE2 gene, and therapy with RAS blockers on the severity of COVID-19]. [PDF]
Probl Endokrinol (Mosk), 2023 Zuraeva ZT +8 more
europepmc +1 more source
[Overview of the prevalence and features of oncological diseases in type 2 diabetes and possible immunological mechanisms]. [PDF]
Probl Endokrinol (Mosk)Dvoryanchikov YV +3 more
europepmc +1 more source
[Short stature due to intrauterine growth retardation. Clinical and hormonal-metabolic features, possibilities of growth-stimulating therapy]. [PDF]
Probl Endokrinol (Mosk), 2022 Nagaeva EV.
europepmc +1 more source